{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:20:46Z","timestamp":1770690046266,"version":"3.49.0"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100015339","name":"ACCP Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Am Coll Clin Pharm"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In 2022, North Carolina (NC) passed a bill authorizing immunizing pharmacists to dispense HIV post\u2010exposure prophylaxis (PEP) pursuant to a statewide protocol. This survey evaluated NC community pharmacists' knowledge, acceptability, appropriateness, and feasibility of pharmacist\u2010initiated HIV PEP pursuant to the statewide protocol, and evaluated the barriers and facilitators to the implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online 15\u2010min Qualtrics (Qualtrics, Provo, UT) survey was emailed to practicing NC community pharmacists registered with the NC Board of Pharmacy. Data was collected between March and April 2025. Descriptive statistics are reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 569 pharmacists responded (response rate\u2009=\u20099.3%), with 447 eligible pharmacist responses. Respondents were predominantly white (81%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009362), female (67.8%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009303), and practicing at a national chain pharmacy (38.4%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009174). Fifty percent (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009280, 50%) of pharmacists noted that they were unaware of the NC standing protocol authorizing pharmacists to dispense HIV PEP. Most pharmacists felt slightly knowledgeable about current HIV PEP regimens (48.5%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009216), and most pharmacists (68.7%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009307) were slightly or very willing to initiate HIV PEP according to the statewide protocol. Respondents perceived the benefits of pharmacist\u2010initiated HIV PEP to be increased access to preventative care in the community (69.9%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009391) and reduced transmission of HIV (64.6%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009361), and the most commonly perceived barriers include a lack of time (68%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009304) and staff to incorporate this into the workflow (65.8%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009294). Pharmacists also perceived a lack of training (52.3%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009234) and a lack of financial reimbursement for HIV PEP (50.3%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009225) as barriers to implementation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Despite limited awareness of the statewide protocol, most pharmacists are willing to dispense HIV PEP pursuant to the statewide protocol. Insurance coverage for pharmacist time to assess the patient and dispense HIV PEP along with training for community pharmacists on how to implement pharmacist\u2010initiated HIV PEP into practice is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jac5.70149","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:29:32Z","timestamp":1763641772000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Implementation of Community Pharmacist\u2010Initiated Human Immunodeficiency Virus Post\u2010Exposure Prophylaxis: A Cross\u2010Sectional Survey Study"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-0631","authenticated-orcid":false,"given":"Grace T.","family":"Marley","sequence":"first","affiliation":[{"name":"University of North Carolina Eshelman School of Pharmacy  Chapel Hill North Carolina USA"},{"name":"South East Area Health Education Center  Wilmington North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimah","family":"Hussein","sequence":"additional","affiliation":[{"name":"University of North Carolina Eshelman School of Pharmacy  Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda H.","family":"Corbett","sequence":"additional","affiliation":[{"name":"University of North Carolina Eshelman School of Pharmacy  Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"\u201cHIV Diagnosis Rate: Number (Total) of New HIV Diagnoses in North Carolina Per 100 000 Population \u201daccessed May 19 2025 https:\/\/embed.clearimpact.com\/Measure\/Embed?id=100005064."},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7401a1"},{"key":"e_1_2_10_4_1","unstructured":"\u201cPost\u2010Exposure Prophylaxis (PEP) | NIH \u201daccessed August 18 2024 https:\/\/hivinfo.nih.gov\/understanding\u2010hiv\/fact\u2010sheets\/post\u2010exposure\u2010prophylaxis\u2010pep."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.1.85"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.07.003"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/17151635241267350"},{"key":"e_1_2_10_8_1","unstructured":"T. W.House \u201cNational HIV\/AIDS Strategy for the United States 2022\u20132025.\u201d"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2023.09.001"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2024.102084"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2021.08.001"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26232"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.06.005"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad549"},{"key":"e_1_2_10_15_1","unstructured":"S. H.Little \u201cHiv Pep Dispensing Protocol \u201dNorth Carolina Board of Pharmacy accessed October 14 2025 https:\/\/www.ncbop.org\/downloads\/HIVPEPDispensingProtocol.pdf."},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012\u2010017\u20100635\u20103"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy12050144"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12222315"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.24926\/iip.v14i1.5091"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.46542\/pe.2021.211.517527"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.14045"},{"key":"e_1_2_10_22_1","unstructured":"CDC \u201cClinical Testing Guidance for HIV. HIV Nexus: CDC Resources for Clinicians \u201d2025 https:\/\/www.cdc.gov\/hivnexus\/hcp\/diagnosis\u2010testing\/index.html."},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002945"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000257839.83765.07"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.10.005"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190012468451"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy9020084"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2020.04.007"},{"key":"e_1_2_10_29_1","unstructured":"\u201cHIV Post\u2010Exposure Prophylaxis Certificate Program \u201daccessed September 11 2025 https:\/\/cpe.pharmacy.ufl.edu\/hiv\u2010post\u2010exposure\u2010prophylaxis\u2010certificate\u2010program\/."},{"key":"e_1_2_10_30_1","unstructured":"\u201cPharmacy\u2010Based HIV Prevention Services \u201daccessed September 11 2025 https:\/\/www.pharmacist.com\/Education\/Certificate\u2010Training\u2010Programs\/Pharmacy\u2010Based\u2010HIV\u2010Prevention\u2010Services."},{"key":"e_1_2_10_31_1","unstructured":"\u201cSTI\/HIV Training Modules for Pharmacists Available\u2014NACCHO \u201daccessed September 11 2025 https:\/\/www.naccho.org\/blog\/articles\/sti\u2010hiv\u2010training\u2010modules\u2010for\u2010pharmacists\u2010available."},{"key":"e_1_2_10_32_1","unstructured":"Store ASHP \u201cPharmacist\u2010Initiated Therapy Microcredential: HIV Pre\u2010 and Post\u2010Exposure Prophylaxis \u201daccessed September 11 2025 https:\/\/store.ashp.org\/Default.aspx?TabID=251&productId=925473783&srsltid=AfmBOoqbkwwBQhsH4T5vhs77oiceMsMUFJuyP4_ay4kUYuYfuXtr0P4W."},{"key":"e_1_2_10_33_1","unstructured":"\u201cAmerican Academy of HIV Medicine | HIV Pharmacist \u201daccessed September 11 2025 https:\/\/aahivm.org\/hiv\u2010pharmacist\/."},{"key":"e_1_2_10_34_1","unstructured":"\u201cTruvada Prices Coupons & Savings Tips\u2014GoodRx \u201daccessed May 19 2025 https:\/\/www.goodrx.com\/truvada?ppid=3."},{"key":"e_1_2_10_35_1","unstructured":"\u201cIsentress Prices Coupons & Savings Tips\u2014GoodRx \u201daccessed May 19 2025 https:\/\/www.goodrx.com\/isentress?ppid=3."},{"key":"e_1_2_10_36_1","unstructured":"\u201cTivicay Prices Coupons & Savings Tips\u2014GoodRx \u201daccessed May 19 2025 https:\/\/www.goodrx.com\/tivicay."},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2024.00192"},{"key":"e_1_2_10_38_1","unstructured":"AIDSVu \u201cAIDSVu Releases New PrEP Data and Launches PrEPVu.Org A New PrEP Equity Platform \u201d2024 https:\/\/aidsvu.org\/news\u2010updates\/aidsvu\u2010releases\u2010new\u2010prep\u2010data\u2010and\u2010launches\u2010prepvu\u2010org\u2010a\u2010new\u2010prep\u2010equity\u2010platform\/."},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.1773"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2018.04.007"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.14014"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2016.05.004"},{"key":"e_1_2_10_43_1","unstructured":"M.Vinson \u201cBreaking Barriers: Advancing PrEP Access For All in the Southern U.S. Southern AIDS Coalition \u201d2024 https:\/\/southernaidscoalition.org\/breaking\u2010barriers\u2010advancing\u2010prep\u2010access\u2010for\u2010all\u2010in\u2010the\u2010southern\u2010u\u2010s\/."},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461\u2010018\u20102305\u20100"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2015.07.003"}],"container-title":["JACCP:  JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jac5.70149","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jac5.70149","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jac5.70149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:47:32Z","timestamp":1770626852000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jac5.70149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/jac5.70149"],"URL":"https:\/\/doi.org\/10.1002\/jac5.70149","archive":["Portico"],"relation":{},"ISSN":["2574-9870","2574-9870"],"issn-type":[{"value":"2574-9870","type":"print"},{"value":"2574-9870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"2025-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70149"}}